NMOSD acute attack: Understanding, treatment and innovative treatment prospect

J Neuroimmunol. 2020 Nov 15:348:577387. doi: 10.1016/j.jneuroim.2020.577387. Epub 2020 Sep 8.

Abstract

Neuromyelitis optica spectrum disorder (NMOSD) is a group of severe inflammatory demyelinating disorders of the central nervous system that involves the optic nerve and spinal cord. Currently the therapeutic options for an acute attack in NMOSD are limited and rarely characterized in clinical studies. This review discussed the overall characteristics of acute attack of NMOSD, related risk factor, prognosis and management. Considering the huge unmet needs and the emergence of new therapeutic targets, we also reviewed innovative treatments that might alleviate attack damage, along with the challenges to evaluate new drug for acute attack in NMOSD.

Keywords: Acute attack; Innovative treatment; Neuromyelitis optica spectrum disorder; Risk factor; Severe attack.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Humans
  • Immunotherapy / methods*
  • Neuromyelitis Optica / drug therapy*
  • Neuromyelitis Optica / immunology
  • Neuromyelitis Optica / physiopathology